Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
Developments in Hodgkin lymphoma, CLL, multiple myeloma and follicular lymphoma
Homeless tumour cells in CLL
What does the CLL forum data tell us?
Biosimilars: Making biological agents availble worldwide
Won Seog Kim